P-268: INSURE: a global pooled analysis of patients (pts) with relapsed/refractory multiple myeloma (RRMM) treated with ixazomib-lenalidomidedexamethasone (IRd) in routine clinical practice
Clinical Lymphoma Myeloma and Leukemia（2022）
关键词
multiple myeloma,relapsed/refractory multiple myeloma,ixazomib-lenalidomidedexamethasone
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要